SMAC mimetic BV6 acts in synergy with mTOR inhibitor to increase cisplatin sensitivity in ovarian cancer. Chen Q, Zhang H. Anticancer Drugs 2024 Oct 16. doi: 10.1097/CAD.0000000000001664.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen Q, Zhang H. SMAC mimetic BV6 acts in synergy with mTOR inhibitor to increase cisplatin sensitivity in ovarian cancer. Anticancer Drugs 2024 Oct 16. doi: 10.1097/CAD.0000000000001664.
PMID: 39423314